| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $128,664 ) |
| | 2024 | 2024 | INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) | 123 OLD BROMPTON ROAD | LONDON | | | | GBR | OT2CA297824 | PROTECT - Develop therapeutics to target oncogenic drivers of solid tumours in children | 000 | 1 | NIH | 9/6/2024 | $128,664 |
| | 2024 | 2023 | INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) | 123 OLD BROMPTON ROAD | LONDON | | | | GBR | OT2CA278743 | NexTGen - ICR | 000 | 1 | NIH | 9/18/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $107,093 ) |
| | 2023 | 2023 | INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) | 123 OLD BROMPTON ROAD | LONDON | | | | GBR | OT2CA278743 | NexTGen - ICR | 001 | 1 | NIH | 8/1/2023 | $107,093 |
| | 2023 | 2022 | INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) | 123 OLD BROMPTON ROAD | LONDON | | | | GBR | OT2CA278743 | NexTGen - ICR | 000 | 1 | NIH | 5/26/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $123,602 ) |
| | 2022 | 2022 | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL | 123 OLD BROMPTON RD | LONDON | | | | GBR | OT2CA278743 | NexTGen - ICR | 000 | 1 | NIH | 6/22/2022 | $123,602 |
|
|
